Your browser doesn't support javascript.
Significantly reduced abilities to cross-neutralize SARS-CoV-2 variants by sera from convalescent COVID-19 patients infected by Delta or early strains.
Pan, Ting; Hu, Zhongwei; Hu, Fengyu; Zhang, Yiwen; Liu, Bingfeng; Ke, Changwen; She, Qiumin; He, Xin; Tang, Xiaoping; Zhang, Hui.
  • Pan T; Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Hu Z; Center for Infection and Immunity Study, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, China.
  • Hu F; Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Zhang Y; Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Liu B; Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Ke C; Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.
  • She Q; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, China.
  • He X; Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Tang X; Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China. hexin59@mail.sysu.edu.cn.
  • Zhang H; Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China. tangxp@gzhmu.edu.cn.
Cell Mol Immunol ; 18(11): 2560-2562, 2021 11.
Article in English | MEDLINE | ID: covidwho-1462001
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Neutralization Tests / SARS-CoV-2 / COVID-19 Type of study: Randomized controlled trials Topics: Variants Limits: Adult / Aged / Humans / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Cell Mol Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: S41423-021-00776-8

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Neutralization Tests / SARS-CoV-2 / COVID-19 Type of study: Randomized controlled trials Topics: Variants Limits: Adult / Aged / Humans / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Cell Mol Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: S41423-021-00776-8